Learn how Flowhub cannabis retail management solutions can help improve sales, compliance, and daily operations.
2024 Marijuana Industry Statistics & Data Insights
How the industry is performing and where it's headed
For the cannabis industry, the only constant is change. Marijuana regulations, laws, sentiment, technology and business practices evolve each year—meaning there’s a long list of new data and insights to unpack.
To paint a clear picture of the cannabis industry, we scoured the internet to find the most important and relevant marijuana statistics for 2024.
In this report, you’ll see marijuana use statistics, the national sentiment around weed acceptance/accessibility, marijuana market growth, employment trends, and legal facts.
Let’s dive into the findings.
Key findings:
Half of Americans have tried cannabis.
79% of Americans live in a county with at least one dispensary.
There are 440,445 full-time equivalent jobs supported by legal cannabis.
The US cannabis industry is expected to reach almost $40 billion in 2024.
1 in 3 women over 21 consume cannabis.
Cannabis will add $115.2 billion to the economy in 2024.
Adult-use cannabis is now legal in 24 states.
Support for legalizing cannabis hit a record 70%.
Ranks of women and minority cannabis executives are rebounding.
Cannabis earns higher tax revenue than alcohol in 9 states.
Average retail cannabis prices dropped -32% since 2021.
Dispensaries accepting debit earn an average of $4,627 more than cash only retailers.
1. Marijuana usage statistics
12% of Americans identified as “current users”
The most recent Gallup poll (from 2019), shows that 12% of Americans are active marijuana users, which is down slightly (from 13% in 2016).
From 2013 to 2016, the number of people who use marijuana nearly doubled. Since then, the rate of use has stayed relatively flat.
Marijuana usage statistics
Half of Americans have tried cannabis
According to Gallup, fully half (50%) of Americans say they have tried marijuana at some time, which is a new high point.
In an answer to a separate question, roughly one in six Americans (17%) say they "smoke marijuana." This is also a new high for Gallup.
Beverages, edibles, vape pens, and pre-rolls rise in popularity
Headset found that cannabis tinctures(-24%), topicals(-8%), capsules(-4%), and flower(-8%) sales declined in 2022. Alternatively, there was a spike in sales of products like beverages(+10%), edibles(+10%), vapes(+5%), and pre-rolls(+12%).
This product category shift is possibly attributed to changing consumer behavior from medicinal cannabis consumption to more recreational use.
Instead of shopping for cannabis products to treat symptoms, consumers are hinting at a greater interest in portable, shareable recreational products.
1 in 3 women over 21 consume cannabis
A recent study conducted by The Harris Poll on behalf of MedMen found more than one-third (37%) of American women aged 21+ consume cannabis.
The national survey also uncovered women primarily use cannabis for therapeutic reasons. The top three reasons women use cannabis is to relieve anxiety (60%), help them sleep (58%), and relieve pain (53%).
Many of these female cannabis consumers are doing so privately. The study found 65% of women who use cannabis say there are people in their lives who still do not know they are doing so, including their parents, children, and coworkers.
Cannabis consumers diversified (though gender is nearing 50/50)
The cannabis consumer continues to diversify.
The 2020 report from Eaze, a cannabis delivery service in the San Francisco Bay Area, shows the divide in gender disappearing, especially in the boomer age group.
Regarding age, Eaze’s 2019 report showed consumers age 50+ increasing by 105%. They also purchased 67% more topicals than in 2018.
2020 sales by generation from dispensaries using Flowhub shows the generational breakdown of customers as:
Pre-rolls are exploding in popularity
Pre-rolls are the third largest product category in the US after Flower and Vapor Pens. They’ve exploded in popularity since the start of 2022.
Headset found when comparing the first eight months of 2023 to the previous year, US pre-roll sales increased by 13.4%, outperforming other categories like edibles or concentrates by a large amount.
Pre-rolls are also capturing a significantly larger share of total dispensary sales. In the US, pre-rolls captured 15.3% of total sales, up 32% from 11.6% in January 2022.
79% of Americans live in a county with at least one dispensary
Most Americans now live in a state that has legalized cannabis. Pew Research broke down the details to find:
- 54% of Americans live in a state where the recreational use of marijuana is legal.
- 74% of Americans live in a state where cannabis is legal for either recreational or medical use.
- 79% of Americans live in a county with at least one cannabis dispensary.
- There are nearly 15,000 cannabis dispensaries in the United States.
- California has far more dispensaries than any state: 3,659 at the time of this analysis, more than double the amount in the second-highest ranking state. A quarter of all marijuana dispensaries in the U.S. are in California, and nearly all Californians (99.5%) have a dispensary in their county. Los Angeles County alone has more dispensaries (1,481) than any state other than California itself.
- Oklahoma has the most marijuana dispensaries per capita of any state: 36 dispensaries for every 100,000 residents.
2020 Cannabis Sales by Generation
Medical
- Gen Z 17%
- Millennials 42%
- Gen X 23%
- Boomers 17%
- Silent Gen 1%
Recreational
- Gen Z 17%
- Millennials 48%
- Gen X 21%
- Boomers 13%
- Silent Gen 1%
21% of Dry January participants are replacing alcohol with cannabis and CBD
A recent survey from CivicScience found that 21% of people doing Dry January — a popular trend where you abstain from alcohol for the month — are replacing alcohol with cannabis and CBD.
The same survey uncovered that the largest demographic of people replacing alcohol with cannabis are aged 21-24 (34%), followed by 25-34-year-olds (24%).
We’ve seen this trend of younger individuals replacing alcohol with cannabis rising since the pandemic. These Dry January statistics confirm the assumption that more people from younger generations are turning away from alcohol and using cannabis as an alternative.
Similarly, cannabis data firm, Headset, found that from 2019 to 2020, Generation Z had 127% sales growth, compared to just 5% for boomers.
This could be due to Gen Z aging into the market every day, but the pandemic also played a role in older generations and their willingness to go out and shop (or use ecommerce).
Younger consumers prefer cannabis vape pens
Together, Gen Z and Millennials make up 62.8% of all US cannabis sales and 70.8% of all Vapor Pen sales based on data from Headset.
Gen Z is already known to be attracted to nicotine vaporizers, which influences the way they consume cannabis. This is likely due to their familiarity with the consumption method since we see diminishing Vapor Pen preference with increasing age.
Nationwide sales increased 67% in 2020
Analysts attribute this massive increase both to changing public perception, but also to the pandemic. More home-bound than ever, and with ongoing fear of shutdowns, people stocked up on cannabis to the tune of nearly $18 billion.
Flowhub data from the State of the Cannabis Industry 2020 report shows the percent change in total sales from 2019 to 2020.
Even during the summer of 2020, when most states were shut down, dispensaries saw increased average order size and thus, increased revenue, even as people shopped less frequently.
Delivery and online ordering reigned supreme
Online ordering, curbside pickup, and delivery were big trends in 2020 that helped consumers get their products quickly and safely.
According to Eaze, in the 30 days following the March 13 declaration of a national emergency, new delivery customer sign-ups jumped by nearly 60%.
Similarly, the State of the Cannabis Industry found that stores with order ahead enabled sold 22% more on average compared to stores without order ahead. Not surprisingly, tech companies in cannabis ecommerce, like Dutchie, dramatically increased their market share in 2020.
The total U.S. cannabis supply is expected to top 48.8 million pounds
Whitney Economics calculated that the total amount of cannabis (both legal and illegal) will exceed 48.8 million pounds in 2022.
Their report also projects there will be more legal cannabis than illicit cannabis in the U.S. by 2026.
Cannabis cultivation is ramping up across the country. A common cultivation trend in new markets is a shortage of cannabis immediately following regulation, then an overproduction as the state ramps up production to meet demand, and eventually an equilibrium between marijuana supply and demand.
Cannabis product type preferences changed
As consumers change, so do their THC preferences.
In 2019, Eaze saw vape sales decrease by 15% after “vape gate.” Those consumers turned toward edibles (up 24% in Oct. 2019).
2020 followed suit, with edibles being the most popular product category, accounting for 22% of all sales for Eaze.
Speculation was that because COVID-19 is a respiratory illness, consumers would shift away from inhalables.
Leaflink, a cannabis industry wholesale marketplace, found that at the start of the COVID-19 pandemic, inhalables remained popular. And that trend continued throughout 2020, despite flower shortages in some key states like California and Colorado.
14% of Americans use CBD products
CBD is a broad category, and has hit mainstream since becoming federally legal in 2018. While marijuana users and CBD users may be different, it’s important to note usage in this group.
According to Gallup, 14% of all U.S. adults use CBD. This jumps to 20% for those ages 18-29.
Perhaps most interesting is the question of familiarity with CBD products: 49% of those age 65+ are unfamiliar with CBD (compared to just 26% of those age 18-29).
The same study found the most common reasons for using CBD include:
Pain - 40%
Anxiety - 20%
Sleep/Insomnia - 11%
Arthritis - 8%
Migraines/Headaches - 5%
SingleCare, a medical prescription savings company, ran a similar survey in April of 2020 and found that 45% of current CBD users increased their use of CBD once the pandemic began.
Interestingly, their 2020 study found that 49% of CBD users take CBD to help with stress and anxiety, which is nearly 30% more than the 2019 Gallup poll.
Acceptance of marijuana in the US
Marijuana for recreational use is legal in 24 US states
As of January 2024, 24 states, the District of Columbia, and Guam have legalized recreational cannabis use for individuals age 21+: Alaska, Arizona, California, Colorado, Connecticut, Delaware, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Jersey, New Mexico, New York, Ohio, Oregon, Rhode Island, Vermont, Virginia, and Washington.
Delaware, Minnesota, and Ohio were added to the list of legal adult-use cannabis states in 2023.
Medical marijuana is now legal in 40 US states
Medical use of marijuana is now legal in 40 states plus Washington D.C. for medical purposes: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Utah, Vermont, Virginia, Washington, and West Virginia.
Kentucky was added to the list of legal medical cannabis states in 2023.
Support for legalizing cannabis is at a record 70%
According to a recent Gallup poll, seven in 10 Americans think cannabis should be legal, the highest level ever recorded.
The first time Gallup gathered this data in 1969, just 12% of Americans were in favor of legal cannabis.
Medical cannabis improves quality of life for veterans
A recent study published in Clinical Therapeutics found 91% of military veterans who visit providers for medical cannabis said it has improved their quality of life.
Medicinal cannabis use was reported to improve quality of life and reduce unwanted medication use by many of the study participants. The present findings indicate that medicinal cannabis can potentially play a harm-reduction role, helping veterans to use fewer pharmaceutical medications and other substances.
Clinical Therapeutics, June 2023
As marijuana use is more broadly accepted, its prevalence for positive health effects and benefits toward public health are increasing. For veterans struggling with PTSD, substance use, illicit drug use, and more, the cannabis plant has entered as a supplement for traditional health care and prescription drugs.
Cannabis market opportunity
The US cannabis industry is expected to reach almost $40 billion in 2024
According to projections from Statista, total revenue from cannabis is expected to reach $39.85 billion in 2024.
Statista also projects the cannabis market to reach over $67 billion in revenue by 2028 as the legalization movement surrounding cannabis evolves.
Cannabis prices are still compressing, and brands are consolidating
Competitive pricing trends among cannabis brands and retailers has led to significant price declines beginning in 2021. While there are signs this compression is slowing and even rising in some states, it’s important to track this compression.
BDSA Retail Sales Tracking found equivalent average retail prices (EQ ARP) dropped -32% (from their peak in Q3 2021 to Q2 2023). This price decline, along with inflation (which has increased costs for labor and materials for licensees), has made the industry even more competitive.
Compressing prices impact cannabis brands and retailers, squeezing profit margins and forcing dispensaries to fight to combat the effects of marijuana price compression.
For THC brands, price compression has led to considerable consolidation. Across all BDSA-tracked markets, the share of total sales held by the five best-selling brand houses grew by +14% between Q2 2021 and Q2 2023.
Similarly, around 25% of the 50 best-selling flower strains in both California and Colorado come from a single brand. This shows just how competitive (and compressed) the brand landscape is becoming.
Cannabis will add $115.2 billion to the economy in 2024
According to the MJBizFactbook, for every $10 consumers and patients spend at dispensaries, an additional $18 will be injected into the economy.
Much of this economic stimulation happens at the local level, contributing to growth in the same neighborhoods where the cannabis products are being sold.
Illinois: first year of MMJ sales topped $1 billion
Recreational sales started in Illinois in January 2020, and total sales numbers (including both med and rec) topped $1 billion dollars by December.
That’s over 14.5 million products sold — with 25% going to out-of-state residents.
Ranks of women and minority cannabis executives are rebounding
The latest data from the MJBiz Diversity, Inclusion and Equity Report found women account for 39% of cannabis executives while racial minorities reached 24%. This is a significant jump from the past year’s 23% women and 12% racial minorities.
The cause of this jump is still unclear. Andrew Long of MjBizDaily explains, “Diversity returned to the C-suite for reasons that have yet to be determined.”
While they’ve been criticized in the past for falling short, cannabis social equity programs appear to be supporting marginalized groups in the industry.
Cannabis earns higher tax revenue than alcohol
Cannabis is often compared to the alcohol industry, even though the two are innately different.
It appears cannabis isn’t just better for avoiding hangovers, it’s also earning states more money in tax revenue.
The Tax Foundation uncovered the following surrounding cannabis vs. alcohol tax:
“The largest and longest-established markets generated the most [cannabis tax] revenue in California, Washington, and Colorado. In the first quarter of 2023, 10 states—Arizona, Colorado, Maine, Massachusetts, Michigan, Montana, Nevada, New Mexico, Oregon, and Washington—generated more revenue from cannabis than from either alcohol (9 states) or tobacco (Washington).”
In 9 states, cannabis brings in more tax revenue than alcohol—and that number is only expected to rise.
States smashed prior years’ sales records, despite COVID-19
2020 was an odd year, with the onset of a global pandemic, quickly-changing local regulations, and an eventual “essential” status for cannabis businesses.
Throughout all this, though, several states crushed prior year sales records, including mature markets like California, Oregon, and Colorado.
Marijuana Business Daily says experts expect this trend of increasing market size to continue.
Cannabis market trends
Cashless payments improve dispensary performance
Flowhub data from Green Wednesday 2023 found dispensaries accepting debit cards earned an average of $4,627 more per day than cash only retailers.
Additionally, dispensaries offering debit payments processed 59% more transactions compared to cash only dispensaries and transactions paid with a debit card were $13 higher than cash only transactions.
Despite its history of being a cash-based industry, cannabis consumers still want to pay with cards.
We're seeing this trend accelerate in all other industries too. The 2023 McKinsey Global Payments Report found cash usage declined by nearly four percentage points globally in 2022.
Expect to see continued adoption and growth of cannabis debit payments throughout 2024.
Looking for a cannabis payments provider? Get approved in 1 day with Flowhub Pay.
Millennials capture nearly half of every dollar spent on Cannabis in the US
Headset’s Demographics Report notes the millennial age group is the largest demographic of cannabis consumers, capturing 46.2% of every dollar spent on weed.
However, Gen Z is the fastest-growing group of marijuana users, which is quickly eating away at the dominant market share of Millennials. Year-over-year, these young adults’ percentage share of total cannabis sales has grown by 11.3%.
Cannabis capital raises declined in 2020
Investments into cannabis brands, including capital raises, slowed dramatically in 2020.
However, once dispensaries were deemed essential, investors showed renewed interest. $2.6 billion was raised in the first half of 2020 — a 67% decline.
However, following a Democratic election, North American cannabis companies raised over $1.6 billion in January 2021 alone.
SMBs are the engine of the cannabis M&A economy
The contractions of the cannabis industry created a realignment in the sector following the industry’s early explosive success.
Laura A. Bianchi, founding partner of Bianchi & Brandt, explains the situation in a recent Trend Report stating, “We’ve been entrenched in the hyperactive cannabis M&A environment for many years, and after the massive, unexpected pandemic bump—and the ensuing crash of cannabis markets coast to coast—we’re now in The Great Correction. ”
Instead of blockbuster acquisitions and rapid multi-state expansion, we’re seeing small and midsize businesses (SMBs) are now the focus of most M&A activity.
Laura continues in the trend report, explaining “Savvy businesses are looking for mutually beneficial partnerships that allow them to maintain a foothold in the market to ride out this correction. Many of these smaller cannabis businesses are merging for basic survival. Some are finding that their new partnerships are helping them thrive in these conditions. Others are entering into bad partnerships out of desperation, and we will likely see them in court in the future.”
Cannabis mergers and acquisitions were down in 2022, but expected to surge in 2023
Investments into cannabis brands, including capital raises, slowed dramatically in 2022 after a big year in 2021.
Total M&A volume decreased by 62% in the United States compared to 2021, and there were 39% fewer transactions, according to Viridian Capital Advisors.
The merger and acquisition slowdown in cannabis is largely due to rising interest rates and low cannabis stock prices, meaning stock-based M&A deals are more expensive.
It appears that many larger cannabis operators and capital groups played it safe in 2022 while waiting for the market to level out. However, the outlook for 2023 points toward a spike in cannabis mergers and acquisitions, according to several experts.
Cannabis employment demand
The cannabis industry supports 440,445 jobs
The 2024 Vangst Jobs Report found There are 440,445 full-time equivalent jobs supported by legal cannabis as of early 2024. That number represents a 5.4% year-over-year increase, adding 22,952 new jobs over the past twelve months.
This growth was driven largely by steep-curve expansion in young Midwestern markets — Michigan, Missouri, and Illinois — and the moderate growth of East Coast markets like New York, New Jersey, and Connecticut.
Growth in cannabis sales varies by market age
MJBizDaily recently found year-over-year cannabis market growth rates vary by the age of each market.
In new markets like Arizona, Illinois, and Maine, sales continued to grow—but at slower rates than in 2022. For these states, it’s likely the economy that slowed their growth.
At the same time, established markets like Colorado and Nevada did not decline as much as in 2022. For these states, this is a promising sign for 2024.
Senior-level cannabis salaries increased in 2020
According to Vangst’s survey of marijuana industry professionals, median salary for retail roles increased in 2020 (compared to 2019).
Dispensary General Manager salaries increased by 13% and Director of Retail Operations saw a healthy 22% increase.
See the report for details on salaries for retailers, cultivators, extractors, and more.
Key states have considerable job growth potential
Markets like California, New York, New Jersey, Virginia, and more are yet to tap into the full potential of their respective cannabis industries. For example, California has only reached around 83,000 cannabis jobs of a potential 133,000.
In their Jobs Report, Vangst explains, "If state policymakers work together to move legacy market consumers into legal, licensed, tax-paying stores, we should see the return of double-digit job growth."
In 2024, expect the industry to get back on track in terms of revenue and job growth.
Cannabis social equity
Social equity is important to consumers
According to Weedmaps, 57% of cannabis consumers believe everyone should have access to cannabis industry opportunities, with just as many people believing that everyone would benefit from those equal opportunities.
46% of respondents said they want to frequently visit women-owned cannabis businesses, 44% want to support minority-owned cannabis businesses, and 37% say they want to buy from LGBTQ+-owned businesses.
See this Guide to Social Equity Programs for dispensaries for a list of programs available in cannabis.
Leadership diversity in cannabis is stagnant or declining
In 2022, non-white ownership of cannabis businesses shrank to 15.4% from 20.7% in 2021 according to a report from MJBizDaily. Additionally, the percentage of leadership positions held by U.S. women and racial minorities has remained stagnant or declined in the past five years.
Looking at the data by sector, we see some employment areas are faring better than others. 38% of cannabis technology executives and 32% of cultivation executives are people of color, while 42% of cannabis nonprofit executives and 57% of cannabis media companies are women.
It’s clear that there is still work to be done to build a truly fair and equitable cannabis industry. Though some sectors are doing better than others, groups are still fighting to ensure every area of this industry is equally representative of the diversity we see across the United States.
Cannabis shoppers are researching online before they buy
A recent data dive from BDSA explores the actions dispensary shoppers take before they buy. The report found frequent cannabis shoppers are more likely to prepare for a purchase by researching online.
42% of frequent dispensary shoppers report going online to see the menu at a specific dispensary. This “regular shopper” cohort was also more likely to look for deals and promotions (30% of weekly shoppers compared to 17% of less than monthly shoppers).
The BDSA report also shows planning for purchases differs based on how much consumers spend. Shoppers in the top 25th percentile of per-visit-spending do more online research before replenishing (42% report checking dispensary menus).
In 2024, easily accessible dispensary websites will become increasingly important. Retailers can lean on these cohorts of "researcher-first buyers" by optimizing product pages to rank higher on Google.
6. Legal updates
Cannabis won the 2020 elections
Every cannabis-related ballot measure in 2020 passed, including a few new medical markets, and several new recreational markets.
South Dakota was the first state to legalize medical and recreational marijuana at the same time.
And with 1 in 3 Americans now living in legal states, the rest of the U.S. is facing pressure to legalize as well.
Immediately after the election, with Joe Biden winning and Democrats taking control of the House and Senate, legalization conversations intensified.
New York, followed by the rest of the Northeast, is making headlines with plans to move legalization forward, recognizing the economic impact and tax revenue of legalization and the desire to stay competitive with neighboring states.
Social equity programs are falling short
The MCBA National Cannabis Equity Report found that the number and efficacy of state social equity programs does not reflect the expressed commitment to achieving equity through cannabis.
The report found that while cannabis is legal for medical or adult use in 37 states, only 15 have social equity programs. Thirteen of the 21 adult-use states and two of the 18 medical-only legal cannabis states have social equity programs.
While social equity is often a priority in most cannabis legislation, it appears there has been a disconnect in effectively rolling out government-led social equity programs in the cannabis industry
Cannabis legal updates
5 states eye adult-use legalization in 2024
After adult-use cannabis was legalized in 3 states in 2023, five more are planning to take cannabis legislation to the polls this year.
Florida, Hawaii, New Hampshire, Pennsylvania and South Dakota have a realistic chance to legalize adult-use marijuana this year, according to Marijuana Moment.
Medical cannabis legalization could advance in 4 states
The dwindling list of states with absolutely no legal cannabis may grow shorter in 2024. Nebraska, North Carolina, South Carolina, and Wisconsin are all moving toward cannabis reform.
We hope to see even more states join this list of legal markets as more consumers and patients will gain access to safe, legal cannabis.
New U.S. Cannabis Council advocates for federal legalization
Several top cannabis businesses, associations, and advocacy organizations joined to create the U.S. Cannabis Council (USCC).
The mission of the council is to “align and unify its members’ collective voices to advance cannabis reform” and also to “focus on securing federal reforms that advance social equity and promote fair, safe, and well-regulated markets nationwide as states continue legalizing cannabis at a rapid rate.”
2024 sets the stage for historic cannabis reform
In this election year, there are significant implications surrounding cannabis. The decisions made in 2024 may represent the biggest reform in federal cannabis policy in the past 40 years.
Here’s a timeline of notable moments that may impact cannabis this year:
October 6, 2022 — President Joe Biden issues a statement saying, “No one should be in jail just for using or possessing marijuana.” He goes on to say he will pardon all prior offenses of simple possession of marijuana and the federal level and urge all state govs. to follow suit. The President also mentions he will be reviewing cannabis’ Schedule I designation.
Aug. 29, 2023 — A letter from the Department of Health and Human Services to Anne Milgram, of the Drug Enforcement Administration (DEA) leaks to Bloomberg. The letter calls for rescheduling cannabis as a Schedule III drug under the Controlled Substances Act.
Sep. 13, 2023 — A report by the Congressional Research Service (CRS) finds the DEA will “likely” reschedule marijuana as it would be improbable for them to contradict the HHS recommendation.
Dec. 22, 2023 — President Biden issues a proclamation that further pardons people who have certain cannabis-related convictions under federal law and also grants clemency to 11 individuals who the President said are serving disproportionately long sentences for nonviolent drug offenses.
Jan. 4, 2024 — The DEA confirms it is reviewing the cannabis rescheduling recommendation.
Jan. 12, 2024 — The U.S. government releases documents related to its ongoing review of marijuana's status under federal law. These documents provide the first official confirmation that health officials recommended the DEA reschedule cannabis officially confirming for the first time that health officials have recommended the Drug Enforcement Administration (DEA) place cannabis in Schedule III of the Controlled Substances Act (CSA).
For now, we can only wait and see what the DEA decides. But one thing is for certain, cannabis policy reform is gaining serious momentum in 2024.
The Senate passed the historic Marijuana Research Bill
In November of 2022, the Senate passed the Medical Marijuana and Cannabidiol Research Expansion Act, a bill introduced to expand research into medications derived from the cannabis plant.
The goal of the bill is to facilitate research on cannabis and its potential health benefits. This will be done by streamlining the application process for scientific cannabis studies and removing existing barriers for researchers.
The Marijuana Research Bill is the first standalone marijuana-related bill to be referred to the president by Congress and pass the Senate.
Germany plans to legalize recreational weed, paving the way for the rest of Europe.
Germany is home to Europe's largest economy and also holds the boldest plan for cannabis legalization on the continent. The country plans to decriminalize the purchase and ownership of small amounts of cannabis under a long-awaited blueprint. Under this proposal, cannabis would be sold in licensed shops.
This news has ignited conversations and rising support for legal cannabis across Europe. Germany, however, is taking a very meticulous approach with regards to regulations, control mechanisms and transparency. Their legal framework may become the standard for the European continent – and potentially reach across the globe.
Thailand legalizes marijuana
In June 2022, Thailand removed marijuana and hemp from the Category 5 narcotics list, essentially decriminalizing the substances.
The change in legislation allows Thais the ability to grow and sell cannabis for medical use.
While this is an exciting step forward for a country that previously had some of the harshest drug laws in the world, there are some legal caveats to Thailand's legal cannabis program. For example, products for food or medicine must contain very low levels of THC and recreational use of marijuana, including smoking in public, is still illegal.
We hope that you've found this collection of cannabis industry statistics to be informative and useful. If you have any other research or statistics that you think would be valuable to include in this resource, please let us know by emailing us at marketingteam@flowhub.com. Your feedback and suggestions will help us continue to improve and expand this resource for the benefit of the cannabis industry. Thank you for your support!